March 2, 2020 / 1:52 PM / a month ago

BRIEF-La Jolla Pharmaceutical Posts Qtrly Loss Per Share Of $0.93

March 2 (Reuters) - La Jolla Pharmaceutical Co:

* LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2019

* LA JOLLA PHARMACEUTICAL CO - FOR THREE MONTHS ENDED DECEMBER 31, 2019, GIAPREZA U.S. NET SALES WERE $7.3 MILLION, UP 74%

* LA JOLLA PHARMACEUTICAL CO QTRLY LOSS PER SHARE $0.93

* LA JOLLA PHARMACEUTICAL - AS OF DECEMBER 31, 2019, CO HAD $87.8 MILLION IN CASH, COMPARED TO $172.6 MILLION AS OF DECEMBER 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below